U.S. flag

An official website of the United States government

NM_001358921.2(COQ2):c.232A>G (p.Met78Val) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Nov 15, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001853076.13

Allele description [Variation Report for NM_001358921.2(COQ2):c.232A>G (p.Met78Val)]

NM_001358921.2(COQ2):c.232A>G (p.Met78Val)

Genes:
LOC112997540:Sharpr-MPRA regulatory region 13773 [Gene]
COQ2:coenzyme Q2, polyprenyltransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q21.23
Genomic location:
Preferred name:
NM_001358921.2(COQ2):c.232A>G (p.Met78Val)
Other names:
232A>G
HGVS:
  • NC_000004.12:g.83284533T>C
  • NG_015825.1:g.5382A>G
  • NM_001358921.2:c.232A>GMANE SELECT
  • NM_015697.9:c.382A>G
  • NP_001345850.1:p.Met78Val
  • NP_056512.5:p.Met128Val
  • NC_000004.11:g.84205686T>C
  • NM_015697.7:c.382A>G
  • NM_015697.8:c.382A>G
Protein change:
M128V; MET128VAL
Links:
OMIM: 609825.0006; dbSNP: rs778094136
NCBI 1000 Genomes Browser:
rs778094136
Molecular consequence:
  • NM_001358921.2:c.232A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_015697.9:c.382A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided; RECLASSIFIED - ADRA2C POLYMORPHISM; RECLASSIFIED - ADRB1 POLYMORPHISM
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002176239Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Nov 15, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

SCV005190155Breakthrough Genomics, Breakthrough Genomics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significancegermlinenot provided

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providednot provided
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in COQ2 in familial and sporadic multiple-system atrophy.

Multiple-System Atrophy Research Collaboration.

N Engl J Med. 2013 Jul 18;369(3):233-44. doi: 10.1056/NEJMoa1212115. Epub 2013 Jun 12. Erratum in: N Engl J Med. 2014 Jul 3;371(1):94.

PubMed [citation]
PMID:
23758206

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002176239.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects COQ2 function (PMID: 23758206). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COQ2 protein function. ClinVar contains an entry for this variant (Variation ID: 60536). This missense change has been observed in individual(s) with multiple system atrophy (PMID: 23758206). This variant is present in population databases (rs778094136, gnomAD 0.07%). This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 128 of the COQ2 protein (p.Met128Val).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Breakthrough Genomics, Breakthrough Genomics, SCV005190155.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 26, 2025